A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression

出版年份 2011 全文链接

标题

作者

关键词

出版物

Volume 10, Issue 1, Pages 92

出版商

Springer Nature

发表日期

2011-07-29

DOI

10.1186/1476-4598-10-92

参考文献

查看 5 条相关文献

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.